As of February 2026 Innovent Biologics has a market cap of $17.11 Billion USD. This makes Innovent Biologics the world's 1310th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.